These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4248289)

  • 41. [Development of resistance to ampicillin in gram negative microorganisms in vitro].
    Braginskaia PS; Shneerson AN; Rezvan SP
    Antibiotiki; 1969 Sep; 14(9):831-4. PubMed ID: 4982965
    [No Abstract]   [Full Text] [Related]  

  • 42. [Combined effect of semi-synthetic penicillins (ampicillin and oxacillin) on clinical strains of gram-positive and gram-negative microorganisms].
    Navashin SM; Petrova MA; Chavdarova VB
    Antibiotiki; 1969 Nov; 14(11):1006-11. PubMed ID: 4985088
    [No Abstract]   [Full Text] [Related]  

  • 43. In vitro activity of carbenicillin against Pseudomonas using the disc diffusion method.
    Washington JA; Hall MM; Fausch CJ; Brackin KL
    Mayo Clin Proc; 1973 Oct; 48(10):718-21. PubMed ID: 4200876
    [No Abstract]   [Full Text] [Related]  

  • 44. Pseudomonas aeruginosa and proteus infections in premature babies and in infants. Therapeutic trial with carbenicillin.
    Korányi G; Pesti E; Somogyi G
    Acta Paediatr Acad Sci Hung; 1970; 11(2):141-50. PubMed ID: 4994152
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical experiences with Ro 6-2580 in dermatology].
    Götz H; Hantschke D
    Chemotherapy; 1969; 14():Suppl:57-65. PubMed ID: 4985485
    [No Abstract]   [Full Text] [Related]  

  • 46. [Transmissible resistance toward polysynthetic penicillins].
    Datta N
    Antibiotiki; 1971 Jun; 16(6):523-5. PubMed ID: 5000147
    [No Abstract]   [Full Text] [Related]  

  • 47. Tobramycin, a new aminoglycoside antibiotic: Experience in urinary tract infections.
    Landes RR; Melnick I; Hoffman A; Fehrenbaker L
    South Med J; 1975 Jan; 68(1):116-7. PubMed ID: 125452
    [No Abstract]   [Full Text] [Related]  

  • 48. [Development of resistance. Problems of chemotherapy in urology].
    Engel D
    Z Arztl Fortbild (Jena); 1977 Sep; 71(18):843-5. PubMed ID: 413268
    [No Abstract]   [Full Text] [Related]  

  • 49. Kanamycin in urinary tract infections.
    Petersdorf RG; Turck M
    Ann N Y Acad Sci; 1966 Jun; 132(2):834-41. PubMed ID: 4960374
    [No Abstract]   [Full Text] [Related]  

  • 50. [Sensitivity of clinical strains of Ps. aeruginosa to aminoglycoside antibiotics, carbenicillin and their combinations].
    Fomina IP; Kuznetsova SM; Navashin SM
    Antibiotiki; 1970 Dec; 15(12):1094-8. PubMed ID: 4322741
    [No Abstract]   [Full Text] [Related]  

  • 51. Gentamicin: Antibacterial activity in vitro and clinical studies.
    Altucci P; Sapio U; Esposito E
    Chemotherapy; 1965-1966; 10(5):312-20. PubMed ID: 4958548
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.
    Wise R; Reeves DS
    Chemotherapy; 1974; 20(1):45-51. PubMed ID: 4210893
    [No Abstract]   [Full Text] [Related]  

  • 53. In vitro susceptibility and resistance of gram negative bacilli to carbenicillin.
    Athar MA
    Hindustan Antibiot Bull; 1970; 13(1):1-7. PubMed ID: 4993698
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical and laboratory studies with tobramycin.
    Geddes AM; Goodall JA; Speirs CF; Gillett AP; Andrews J; Williams JD
    Chemotherapy; 1974; 20(4):245-56. PubMed ID: 4212996
    [No Abstract]   [Full Text] [Related]  

  • 55. Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.
    Knudsen ET; Rolinson GN; Sutherland R
    Br Med J; 1967 Jul; 3(5557):75-8. PubMed ID: 4961466
    [No Abstract]   [Full Text] [Related]  

  • 56. [Synergistic action of the combination ampicillin-isoxazolylpenicillin].
    Metzger K
    Arzneimittelforschung; 1974 Apr; 24(4):471-6. PubMed ID: 4211681
    [No Abstract]   [Full Text] [Related]  

  • 57. [The basic studies on chemotherapy in urinary tract infection due to organisms with resistance to antibiotics (author's transl)].
    Igari J
    Jpn J Antibiot; 1977 Aug; 30(8):596-611. PubMed ID: 409865
    [No Abstract]   [Full Text] [Related]  

  • 58. Susceptibility of Proteus species and Pseudomonas aeruginosa to penicillins and cephalosporins.
    Adler JL; Burke JP; Wilcox C; Finland M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():63-7. PubMed ID: 5000270
    [No Abstract]   [Full Text] [Related]  

  • 59. [Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)].
    Simon C; Leuth M; Malerczyk V
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2460-4. PubMed ID: 4218163
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparative studies in vitro on the antibiotic effectiveness of Terizidon].
    Wewalka G; Rotter M; Werner HP
    Wien Med Wochenschr; 1974 Apr; 124(15):235-8. PubMed ID: 4207337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.